Key result
Smoking was associated with the progression of chronic kidney disease in 11 of 12 studies, with consumption of ≥ 15 packs/year increasing the risk of progression.
Why the study?
Does smoking increase the risk of progression of chronic kidney disease in adults?
Systematic Review
Yes
Does smoking increase the risk of progression of chronic kidney disease in adults?
This systematic review highlights that smoking, especially a cumulative exposure of ≥ 15 pack-years, is a significant risk factor for the progression of chronic kidney disease.
Supports smoking history assessment in CKD risk stratification; extends prior associations with a quantifiable pack-year threshold but leaves causality open.
INTRODUCTION: Chronic kidney disease (CKD) and smoking are public health problems. OBJECTIVE: To assess smoking as a risk factor for progression of CKD. METHODS: We conducted a systematic review in Medline, LILACS, SciELO, Google Scholar, Embase and Trials.gov with articles published until February/2013. Were included: cohort, clinical trials and case-control. Performed in humans, aged ≥ 18 years with smoking as a risk factor for progression of CKD. We excluded studies that reported no smoking and CKD in the title or had proposed to reduce smoking. RESULTS: Among 94 citations, 12 articles were selected. Of these, six were multicenter conducted in developed countries, four were randomized. Males predominated 51-76%. There was associated with smoking progression in 11 studies. It was found that the consumption ≥ 15 packs/ year increases the risk of progression of CKD. CONCLUSION: Smoking is a risk factor for progression of CKD.
No takes yet. Share an insight, caveat, or question.
Júnior et al. (2014) conducted a systematic review in Chronic kidney disease (CKD). Smoking was evaluated on Progression of CKD. Smoking was associated with the progression of chronic kidney disease in 11 of 12 studies, with consumption of ≥ 15 packs/year increasing the risk of progression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: